These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 6811281

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. [Antitumor activity and pharmacological properties of furizil].
    Stukov AN, Kraĭz BO, Aleksandrov VA, Ivin BA, Filov VA.
    Vopr Onkol; 1985; 31(5):52-4. PubMed ID: 4013130
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. [10-years experience with myelobromol treatment of myelofibrosis].
    Klimova NF.
    Haematologia (Budap); 1977; 11(1-2):57-72. PubMed ID: 615089
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. STUDY ON THE DISTRIBUTION AND METABOLISM OF 82BR-LABELLED DIBROMOMANNITOL (DBM) IN NORMAL AND TUMOR-BEARING RATS.
    INSTITORIS L, HORVATH IP, CSANYI E.
    Neoplasma; 1964; 11():245-55. PubMed ID: 14171419
    [No Abstract] [Full Text] [Related]

  • 50. Dibromodulcitol (NSC-104800)--clinical brochure.
    Carter SK.
    Cancer Chemother Rep 3; 1968 Dec; 1(1):165-77. PubMed ID: 4989813
    [No Abstract] [Full Text] [Related]

  • 51. [Some characteristics of the biological action of D, L-1,4-dibromo-1,4-dideoxy-2,3-butanediol].
    Miuller NR, Remizov AL, Belogorodskiĭ VV, Filov VA.
    Farmakol Toksikol; 1975 Dec; 38(5):590-1. PubMed ID: 1191387
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Antitumor activity of cis-dihalogenobis(1-phenyl-1,3-butanedionato) titanium(IV) compounds against Walker 256 carcinosarcoma. A new class of antineoplastic agents.
    Keller HJ, Keppler B, Schmähl D.
    Arzneimittelforschung; 1982 Dec; 32(8):806-7. PubMed ID: 6890355
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Aryl-2-halogenoalkylamines. 23. Derivatives of oxanilic acid and salicylic acid: synthesis and antineoplastic activities.
    Artico M, Ross WC.
    Biochem Pharmacol; 1968 Jun; 17(6):883-91. PubMed ID: 5661351
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Glycosidation of 2,5-anhydro-3,4-di-O-benzyl-D-mannitol with different glucopyranosyl donors: a comparative study.
    Tegdes A, Medgyes G, Boros S, Kuszmann J.
    Carbohydr Res; 2006 May 01; 341(6):776-81. PubMed ID: 16473342
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.